Vaccine strategies for glioblastoma: Progress and future directions

Christopher Jackson, Jacob Ruzevick, Henry Brem, Michael Lim

Research output: Contribution to journalReview articlepeer-review

Abstract

Recent advances in glioblastoma therapy have led to optimism that more effective therapies will improve outcomes. Immunotherapy is a promising approach that has demonstrated the potential to eradicate cancer cells with cellular-level accuracy while minimizing damage to surrounding healthy tissue. Several vaccination strategies have been evaluated for activity against glioblastoma in clinical trials. These include peptide vaccines, polyvalent dendritic cell vaccines, heat shock protein vaccines and adoptive immunotherapy. In this review, we highlight clinical trials representative of each of these approaches and discuss strategies for integrating these therapies into routine patient care.

Original languageEnglish (US)
Pages (from-to)155-167
Number of pages13
JournalImmunotherapy
Volume5
Issue number2
DOIs
StatePublished - Feb 2013

Keywords

  • chemotherapy
  • glioblastoma
  • immunotherapy
  • radiation therapy
  • tumor-associated antigen
  • vaccine

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology

Fingerprint Dive into the research topics of 'Vaccine strategies for glioblastoma: Progress and future directions'. Together they form a unique fingerprint.

Cite this